SLBT — SL Science Holding Ltd catalysts
Next verified catalyst
2026-08-01 — AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08 (month) in 1mo
ESTIMATED |
READOUT
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1/2 · Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse |
SLBT SL Science Holding Ltd | AB8939, Venetoclax |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|